Gemina Laboratories Ltd.
GLABF
$0.73
-$0.1894-20.60%
OTC PK
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -629.10K | -707.40K | -608.20K | -564.20K | -860.20K |
| Total Depreciation and Amortization | 21.60K | 19.60K | 19.80K | 19.70K | 20.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 81.80K | 119.20K | 79.60K | -126.50K | 302.20K |
| Change in Net Operating Assets | 396.80K | 360.80K | -84.10K | 677.00K | 336.70K |
| Cash from Operations | -129.00K | -207.80K | -592.90K | 6.10K | -201.10K |
| Capital Expenditure | -- | -- | -- | 12.00K | -8.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 12.00K | -8.90K |
| Total Debt Issued | 50.00K | 0.00 | 860.00K | 0.00 | 200.00K |
| Total Debt Repaid | -31.50K | -27.00K | -27.70K | -26.40K | -27.00K |
| Issuance of Common Stock | -- | 516.80K | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | -1.60K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.10K | 0.00 | -27.20K | 0.00 | 0.00 |
| Cash from Financing | 7.90K | 357.70K | 593.40K | -19.60K | 127.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | -- | -- | -- | -- |
| Net Change in Cash | -121.00K | 149.80K | 500.00 | -1.40K | -82.60K |